PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025(the "Class Period").
Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,CLICK HERE.
LifeMD, headquartered in New York, New York, provides virtual medical services and prescription delivery.
The lawsuit accuses the Company of overstating its competitive position and issuing unrealistic 2025 financial guidance. According to the complaint, LifeMD failed to disclose increasing customer acquisition costs tied to its RexMD platform and its efforts to promote obesity medications such as Wegovy and Zepbound. The lawsuit claims that LifeMD's statements throughout the Class Period were materially false and misleading and lacked a reasonable basis, ultimately resulting in significant investor losses when the market learned the truth.
If you are a LifeMD investor and would like to learn more about this action, CLICK HEREor please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865.
About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:
Andrew Abramowitz
Senior Counsel
Berger Montague
(215) 875-3015
aabramowitz@bergermontague.com
Caitlin Adorni
Director of Portfolio and Institutional Client Monitoring Services
Berger Montague
(267) 764-4865
cadorni@bergermontague.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-berger-montague-advises-lifemd-inc-nasdaq-lfmd-investors-to-inquire-about-a-securities-fraud-class-action-by-october-27-2025-302580236.html
SOURCE Berger Montague
